No problem. Anyone who supports acceptability, I'll support. Keep it up.
The answer to that question is inconsequential in my opinion. As many have stated, we don't have any real revenue or any "value driven contracts" to see at this point. so if we launch from 2 cents or 10 cents it makes no difference to me and I wouldn't be surprised one way or the other.
Market makers are going to have their way with this stock until the DA is signed, so the stock price, no matter how high you think it should be right now, is inconsequential, again in my opinion.
When the da does get signed, institutional investment funds will smother that manipulation and we will see several days of 100-300% plus gains. Of course, most of that stock price will be based on excitement and what the market assumes could be the valuation of the company. Eventually, revenue will be what decides the stock price.... But with all this talk of global contracts, global reach, strategic partnerships with companies that service 2/3 of the Fortune 500 companies... After all is said and done, that revenue will be factored into the percentage of market share in the it healthcare space. I am only interested in market share. If the CLX consortium can manage to secure a significant portion of the market share, in my opinion, we will kiss the teens.
Take another look at my sticky posts above. I stand by every word.
There are obviously things out of our control, but I'm hopeful that based on the facts surrounding this deal, we are all very well positioned here.
